Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis. Am J Hematol 2015 Nov;90(11):E212-3

Date

08/19/2015

Pubmed ID

26284951

Pubmed Central ID

PMC4618044

DOI

10.1002/ajh.24176

Scopus ID

2-s2.0-84944536944 (requires institutional sign-in at Scopus site)   12 Citations

Author List

Hussain AS, Hari P, Brazauskas R, Arce-Lara C, Pasquini M, Hamadani M, D'Souza A

Authors

Ruta Brazauskas PhD Associate Professor in the Data Science Institute department at Medical College of Wisconsin
Anita D'Souza MD Professor in the Medicine department at Medical College of Wisconsin
Mehdi H. Hamadani MD Professor in the Medicine department at Medical College of Wisconsin
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Marcelo C. Pasquini MD, MS Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Aged
Aged, 80 and over
Amyloidosis
Antineoplastic Agents
Biomarkers
Bortezomib
Creatinine
Cyclophosphamide
Dexamethasone
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Myocardium
Natriuretic Peptide, Brain
Peptide Fragments
Prognosis
Severity of Illness Index
Troponin T